Latest filing published 27 Nov 2006 for CHAD THERAPEUTICS INC, €4,166.
Insider track record
No signal scores available.
John C. Boyd: trading record in brief
John C. Boyd is a declared insider of Chad Therapeutics Inc, with filings sourced from SEC (Form 4). Altogether 2 filings, all relating to 24 November 2006.
No open-market purchase appears, only 2 sales worth €5,691.
On 27 November 2006 came the latest disclosure, an open-market sale for €4,166 in Chad Therapeutics Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John C. Boyd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,823 shares@ US$2.99Common SharesSEC:0001209191-06-061420:0
- 650 shares@ US$3.07Common SharesSEC:0001209191-06-061420:1
2 of 2 declarations